✦ LIBER ✦

Phase I trial of doxil plus cisplatin (DDP) in patients (pt) with advanced malignancies

✍ Scribed by Lyass, O.; Hubert, A.; Tzemach, D.; Lafair, J.; Gabizon, A.

Book ID: 122989026
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 144 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81571-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study of Doxil® and Vinorelbine

Phase I Study of Doxil® and Vinorelbine in Patients with Advanced Malignancies

✍ Laufman, Leslie R.; Spiridonidis, C. Harris; Jones, Jacqueline J.; Rhodes, Virgi 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 124 KB

A phase I–II trial of cisplatin, hyperth

A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies

✍ Terence S Herman; Maxine S Jochelson; Beverly A Teicher; Pamela J Scott; Jorgen 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 911 KB

A phase I trial of gemcitabine plus clad

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases

✍ Olatoyosi M. Odenike; Ronald M. Sobecks; Linda Janisch; Dezheng Huo; Todd M. Zim 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 202 KB

Phase I/II trial with 111in-pentetreotid

Phase I/II trial with 111in-pentetreotide in patients with advanced malignancies

✍ Argiris, Athanassios; Peccerillo, Kathy; Murren, John R.; Cornelius, Eugene; Mod 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A phase I trial of dactinomycin intraven

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

Phase II Trial of Cisplatin Plus Temozol

Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients

✍ Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Elio Maccagnano; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 59 KB